Joshua A. Kazam

2011

In 2011, Joshua A. Kazam earned a total compensation of $35.3K as Former President & CEO at Capricor Therapeutics, a 109% increase compared to previous year.

Compensation breakdown

Option Awards$35,321
Total$35,321

Kazam received $35.3K in option awards, accounting for 100% of the total pay in 2011.

Rankings

In 2011, Joshua A. Kazam's compensation ranked 10,680th out of 10,747 executives tracked by ExecPay.

ClassificationRankingPercentile
All
10,680
out of 10,747
1st
Division
Manufacturing
3,942
out of 3,960
1st
Major group
Chemicals And Allied Products
1,029
out of 1,038
1st
Industry group
Drugs
780
out of 786
1st
Industry
Pharmaceutical Preparations
567
out of 571
1st
Source: SEC filing on October 10, 2013.

Kazam's colleagues

We found two more compensation records of executives who worked with Joshua A. Kazam at Capricor Therapeutics in 2011.

2011

Daron Evans

Capricor Therapeutics

Chief Financial Officer

2011

Richard Brewer

Capricor Therapeutics

Chairman

In-depth

You may also like